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Abstract
Background: The importance of the Internet as a medium for publishing and sharing health and medical information has
increased considerably during the last decade. Nonetheless, comprehensive knowledge and information are scarce and difficult
to find, especially for rare diseases. Additionally, the quality of health or medical information about rare diseases is frequently
difficult to assess for the patients and their family members.
Objective: The aim of this study is to assess the quality of information on the Internet about rare diseases. Additionally, the
study aims to evaluate if the quality of information on rare diseases varies between different information supplier categories.
Methods: A total of 13 quality criteria for websites providing medical information about rare diseases were transferred to a
self-disclosure questionnaire. Identified providers of information on the Internet about rare diseases were invited to fill out the
questionnaire. The questionnaire contained questions about the information provider in general (eg, supplier category, information
category, language, use of quality certificates, and target group) and about quality aspects that reflect the 13 quality criteria.
Differences in subgroup analyses were performed using t tests.
Results: We identified 693 websites containing information about rare diseases. A total of 123 questionnaires (17.7%) were
completely filled out by the information suppliers. For the remaining identified suppliers (570/693, 82.3%), the questionnaires
were filled out by the authors based on the information available on their website. In many cases, the quality of websites was
proportionally low. Furthermore, subgroup analysis showed no statistically significant differences between the quality of information
provided by support group/patient organization compared to medical institution (P=.19). The quality of information by individuals
(patient/relative) was significantly lower compared to information provided by support group/patient organization (P=.001),
medical institution (P=.009), and other associations and sponsoring bodies (P=.001) as well.
Conclusions: Overall, the quality of information on the Internet about rare diseases is low. Quality certificates are rarely used
and important quality criteria are often not fulfilled completely. Additionally, some information categories are underrepresented
(eg, information about psychosocial counseling, social-legal advice, and family planning). Nevertheless, due to the high amount
of information provided by support groups, this study shows that these are extremely valuable sources of information for patients
suffering from a rare disease and their relatives.
(J Med Internet Res 2017;19(1):e23)   doi:10.2196/jmir.7056
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Introduction
The quality of information provided on the World Wide Web
has been highly discussed in the literature for the past few years
(eg, [1-3]). In particular, regarding medical information, the
provision of high-quality information is very important because
misinformation can lead to serious health consequences for the
affected patients. This is particularly relevant for information
on the World Wide Web, where the information is used without
the intervention of a medical professional, even though the
related websites clearly state that this information cannot replace
a medical professional’s consultation [4-9].
In the field of rare diseases, information is scarce; it is difficult
to find the right information as well as to assess the quality of
the provided information in detail [10-12]. Additionally, only
a few medical experts for specific rare diseases have
comprehensive knowledge about the diseases. This limits the
ability of patients to get access to high-quality information
[13,14]. The definitions of rare diseases vary from 12:100,000
in Australia to 75:100,000 in the United States [15]. This study
is set in Germany; therefore, it is based on the European Union
definition that considers diseases to be rare when the prevalence
is less than 50:100,000 [16]. It is estimated that there are
between 5000 and 8000 different rare diseases affecting nearly
30 million people in the European Union and 4 million people
in Germany alone [15,17,18].
A detailed description of the framework of this study can be
found in the literature [19]. In brief, the aim of the project is to
conceptualize and implement a central information portal about
rare diseases in Germany, which refers to existing
quality-assured information sources [20]. The distribution of
information and knowledge about rare diseases is an important
factor to improve the overall situation of people affected by a
rare disease [17,21]. In this context, the Internet as a worldwide
open-access medium has become more important during the
last decade [22,23]. The Internet can improve the distribution
of information about rare diseases to the general public and, in
particular, to medical professionals, patients, and relatives of
patients [22]. For the latter group, the Internet is one of the most
frequently used information resources and often the primary
source to search for information after getting a diagnosis [24].
Nevertheless, patients reported that they are often overstrained
with the information they find on the Internet [25]. Information
is often disordered and refers to different stages of the disease.
Moreover, it is not possible to assess the quality of the
information and to find the right information, such as social-legal
advice [1]. For medical professionals, it is important to have
access to the latest innovative research results and
evidence-based therapeutic options as well as actual contact
details of support groups [26].
The aim of this study is to assess the quality of information on
the Internet about rare diseases. Additionally, the study aims to
evaluate if information about rare diseases (eg, information
provided by support groups) is as reliable as information
provided by medical institutions by performing subgroup
analyses. The assessment is based on 13 quality criteria for
websites providing medical information about rare diseases
[19].
Methods
We divided the methodological framework into several steps.
First, as mentioned previously, 13 quality criteria for websites
providing medical information were included to a self-disclosure
questionnaire. The questionnaire contained questions about the
information provider in general (eg, supplier category,
information categories, language, use of quality certificates, and
target group) and questions about quality aspects reflecting the
13 quality criteria (Textbox 1). The disclosure was not
anonymous because the answers need to be checked by the
authors. The questionnaire was verified and pretested by the
patient organization Alliance of Rare Chronic Diseases Germany
(ACHSE eV) and Orphanet Germany. Additionally, the verified
version of the questionnaire was tested by selected rare disease
information providers, which were randomly identified by an
Internet search.
Second, information providers on the Internet were identified
by an Internet search; all 8000 rare diseases, as listed in the
Orphanet list of rare diseases and synonyms [27], were entered
into the Google search engine by a number of research assistants
from May 2015 to January 2016. This list included all registered
rare diseases and their synonyms. For every disease, the first
two hit lists, meaning the first 20 hits, were screened to identify
information websites in the German language. A random check
with 30 diseases showed that we could assume that a screening
of the first two hit lists of each rare disease was sufficient to
identify all relevant information websites. Websites that
provided information about rare diseases were included in the
database, whereas those that just presented contact data, for
example, with no further information were excluded.
Furthermore, websites providing information about several rare
diseases were included into the database as a singular
information provider. Third, all information providers were
invited by email to fill out the self-disclosure questionnaire
(September 2015 to March 2016). Then, these datasets were
double-checked using the information available on the website.
Data were checked for correctness (eg, does the website provide
information about the stated information category?) and
plausibility (eg, is the description of the process of systematic
or literature research comprehensible?). For all information
providers who did not fill out the questionnaire, the questions
were answered by the authors based on the information available
on the website. For that, authors checked the content and the
characteristics of each identified website carefully. However,
just 10 of 13 quality criteria could be answered by publicly
available information. The remaining three quality criteria,
representing the authoring information, evaluation of
information, and review of information, were not reviewable
by the authors. Consequently, for the main evaluation, these
quality criteria were excluded. In the end, all datasets were
evaluated. Microsoft Access was used for data storage. For data
analysis, both Microsoft Excel and Microsoft Access (versions
2007) were used. Differences in subgroup analyses were
performed using t tests.
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Textbox 1. Quality criteria for websites about rare diseases.
Authoring information
• Do you perform a systematic (literature) search prior to providing information for your home page? If yes, then please describe this process.
• Are experts involved in providing information? If yes, then which field do they belong to?
• Do you document the process of providing information? If yes, then please describe the documentation process.
• Do you inform users about the process of developing information? If yes, please describe the process and provide the respective URL.
Authors
• Is general information about the authors mentioned?
• Are other persons who contributed to developing information mentioned?
• Is user-generated content distinguishable and labeled with a username?
Sources
• Does the information concern primary sources of information?
• If no, then do you quote external sources?
Creation or update date
• Is the creation date of information mentioned?
• Is the update date of information mentioned?
Privacy statement
• Is a privacy policy used to inform the user about the usage, storage, and disclosure of personal data?
• Do you inform the user in a prominent position about the storage of personal data for internal usage (eg, research) with an analysis tool and does
the user has the opportunity to disagree?
• Does the user has to agree actively to the disclosure of personal data to third parties?
Declaration of evidence
• Is all medical information evidence-based and it is discernible on what basis points are made (eg, studies, expert statements)?
• Do you provide references to the limitations of the evidence and set out further evidence needs?
Marking of conflicts of interests
• Are advertisements marked as such plainly?
• Are sponsors named?
• Are targets and purposes of the home page published (eg, commercial interest)?
• Is the funding (except from self-financing) published?
• Are conflicts of interests mentioned?
Consideration of target group
• Is information presented target group-specific?
• Is it discernible to whom the information is addressed (eg, patients, doctors)?
Evaluation of information
• Does an archive with former or changed contents exist?
• Is all information checked consistently regarding correctness and accuracy?
Review of information
• Does an internal review process (content quality assessment) for the evaluation of contents exist? If yes, then please describe the process.
Characteristics of the website (accessibility)
• Did you check the website for accessibility through a BITV-Test? (The BITV-Test is a comprehensive accessibility evaluation instrument.) If
yes, how many points has the website scored in this test?
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Is the font size of the website adjustable?•
• Do you consider persons with color vision deficiency in the website coloration?
• Is the main menu selectable without a mouse?
• Information is available in a simple language (eg, according to the rules of the network Simple Language).
• Is the website’s content readable by a software tool?
• Is it possible to subscribe to a newsletter?
• Is information available in a printed version?
• Are the contents shown in multimedia (eg, in terms of videos and photos)?
Imprint
• Is the imprint created according to § 5 TMG/§ 55 RStV following German law?
Contact facility
• Do users have the facility to provide feedback or to get in touch with the operator?
• Is a contact sheet easy to access?
Results
Overall, we identified 693 information suppliers on the Internet
providing information about rare diseases in the German
language or from German-speaking countries. A total of 123
questionnaires (17.7%) were completely filled out by the
information suppliers. For the remaining identified suppliers
(570/693, 82.3%), the questionnaires were filled out by the
authors, omitting the questions referring to quality criteria
representing the authoring information, evaluation of
information, and review of information. A list of the identified
information supplier is available from the corresponding author
on reasonable request.
Most of the websites were located in Germany (632/693, 91.2%),
Austria (21/693, 3.0%), or Switzerland (40/693, 5.8%);
therefore, most of the sites were available in the German
language (682/693, 98.4%). However, some were available
only, or additionally, in the English language (108/693, 15.6%).
The fact that websites can be available in more than one
language has to be taken into account. The majority of websites
were those of patient organizations or support groups (269/693,
38.8%). Other important providers were medical institutions
(186/693, 26.8%), other associations and sponsoring bodies
(65/693, 9.4%), and individuals (eg, patient/relative; 52/693,
7.5%). The three most frequent information categories of all
information suppliers were information about disease
patterns/symptoms (633/693, 91.3%), information about
diagnostics (517/693, 74.6%), and information about medication,
curative means, and aids (359/693, 51.8%). Little information
was available about psychosocial counseling (49/693, 7.1%),
in particular. As a target group, adults were most frequently
addressed (662/693, 95.5%). All characteristics are shown in
detail in Table 1.
Tables 2 and 3 show the comparison and distribution between
supplier and information categories. For instance, it can be seen
that information provided by individuals mostly focused on
disease patterns/symptoms, wherby information provided by
medical institutions additionally focused on diagnostics.
Furthermore, information exchange with other patients and
information about psychological counseling were mostly
provided by support groups/patient organizations.
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Table 1. Characteristics of information providers (N=693).
n (%)Item
Supplier category
269 (38.8)Support group/patient organization
186 (26.8)Medical institution
65 (9.4)Other associations and sponsoring bodies
52 (7.5)Individual (patient/relative)
40 (5.8)Expert association
29 (4.2)Individual (medical expert)
26 (3.8)Pharmaceutical or medical technology company
21 (3.0)Publishing or media company
5 (0.7)Other
Information category (multiple answers possible)
633 (91.3)Disease pattern/symptoms
517 (74.6)Diagnostics
359 (51.8)Medication, curative means, and aids
347 (50.1)Assistance for self-help
320 (46.2)Information exchange with other patients
317 (45.7)Other therapy options
254 (36.7)Research
164 (23.7)Personal advice
128 (18.5)Training and continued education
116 (16.7)Advice from doctors
101 (14.6)Therapeutic guidelines
93 (13.4)Desire to have children/family planning
86 (12.4)Social-legal advice
49 (7.1)Psychosocial counseling
Language (multiple answers possible)
682 (98.4)German
108 (15.6)English
Country
632 (91.2)Germany
40 (5.8)Switzerland
21 (3.0)Austria
Target group (multiple answers possible)
662 (95.5)Adults
235 (33.9)Children
221 (31.9)Medical professionals
Self-disclosure
123 (17.7)Accomplished by the supplier
570 (82.3)Accomplished by authors
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Table 2. Comparison and distribution between supplier (individual-medical expert, individual-patient/relative, expert association, medical institution,
and pharmacetuical or medical technology company) and information categories.
SupplierCategory
Pharmaceutical or
medical technology
company
Medical institutionExpert associationIndividual (patient/rel-
ative)
Individual (medical
expert)
Supplier
%
n (%)Supplier
%
n (%)Supplier
%
n (%)Supplier
%
n (%)Supplier
%
n (%)
84.622 (6.1)42.579 (22.0)45.018 (5.0)50.026 (7.2)41.412 (3.3)Medication, curative means,
and aids
11.53 (0.9)4.38 (2.5)15.06 (1.9)78.941 (12.8)27.68 (2.5)Information exchange with
other patients
80.821 (4.1)85.0158 (30.6)75.030 (5.8)51.927 (5.2)75.922 (4.3)Diagnostics
19.25 (2.0)49.592 (36.2)50.020 (7.8)21.211 (4.3)37.911 (4.3)Research
0.00 (0.0)24.746 (35.9)32.513 (10.2)5.83 (2.3)20.76 (4.7)Training and continued edu-
cation
42.311 (3.2)17.232 (9.2)42.517 (4.9)40.421 (6.1)31.09 (2.6)Assistance for self-help
19.25 (5.4)7.514 (15.1)2.51 (1.1)11.56 (6.5)17.25 (5.4)Desire to have children/fam-
ily planning
88.523 (3.6)88.7165 (26.1)80.032 (5.1)90.447 (7.4)96.628 (4.4)Disease pattern/symptoms
19.25 (3.0)22.041 (25.0)17.57 (4.3)3.92 (1.2)20.76 (3.7)Personal advice
0.00 (0.0)5.410 (20.4)5.02 (4.1)0.00 (0.0)0.00 (0.0)Psychosocialcounseling
42.311 (3.5)52.798 (30.9)37.515 (4.7)51.927 (8.5)55.216 (5.0)Other therapy options
15.44 (4.7)7.013 (15.1)7.53 (3.5)3.92 (2.3)3.51 (1.2)Social-legal advice
7.72 (2.0)14.026 (25.7)25.010 (9.9)5.83 (3.0)20.76 (5.9)Therapeutic guidelines
19.25 (4.3)33.362 (53.5)45.018 (15.5)0.00 (0.0)13.84 (3.4)Advice from doctors
Table 3. Comparison and distribution between supplier (support group/patient organization, publishing or media company, other associations and
sponsoring bodies, and other) and information categories.
SupplierCategory
OtherOther associations and
sponsoring bodies
Publishing or media
company
Support group/patient
organization
Supplier
%
n (%)Supplier
%
n (%)Supplier
%
n (%)Supplier
%
n (%)
60.03 (0.8)55.436 (10.0)71.415 (4.2)55.0148 (41.2)Medication, curative means, and aids
0.00 (0.0)36.924 (7.5)14.33 (0.9)84.4227 (70.9)Information exchange with other patients
80.04 (0.8)64.642 (8.1)95.220 (3.9)71.8193 (37.3)Diagnostics
40.02 (0.8)50.833 (13.0)19.14 (1.6)28.376 (29.9)Research
0.00 (0.0)24.616 (12.5)14.33 (2.3)15.241 (32.0)Training and continuededucation
20.01 (0.3)44.629 (8.4)19.14 (1.2)82.9223 (64.3)Assistance for self-help
0.00 (0.0)9.26 (6.5)23.85 (5.4)19.051 (54.8)Desire to have children/family planning
100.05 (0.8)81.553 (8.4)100.021 (3.3)96.3259 (40.9)Disease pattern/symptoms
0.00 (0.0)18.512 (7.3)0.00 (0.0)33.891 (55.5)Personal advice
0.00 (0.0)6.24 (8.2)0.00 (0.0)12.333 (67.4)Psychosocial counseling
80.04 (1.3)36.924 (7.6)66.714 (4.4)40.2108 (34.1)Other therapy options
0.00 (0.0)13.99 (10.5)0.00 (0.0)20.154 (62.8)Social-legal advice
0.00 (0.0)15.410 (9.9)33.37 (6.9)13.837 (36.6)Therapeutic guidelines
20.01 (0.9)21.514 (12.1)14.33 (2.6)3.49 (7.8)Advice from doctors
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As a first investigation, all identified websites about rare diseases
were analyzed for the use of quality certificates. The majority
of websites about rare diseases did not use certifications or
quality seals. Of the 693 websites analyzed, only 28 (4.0%)
were certified by the international Health on the Net Foundation
Code of Conduct (HONcode) [28]. Additionally, some were
certified by the German certification programs German Action
Forum Health Information System (afgis) [29] (7/693, 1.0%)
or Medisuch [30] (8/693, 1.2%).
Table 4 shows the results for the evaluation of the quality of
information on the Internet about rare diseases. The quality
criteria authoring information, evaluation of information, and
review of information were based on the datasets from the 123
questionnaires that were filled out by the information supplier.
All other quality criteria were based on the datasets of all
information providers. It was examined whether the information
of websites satisfied the defined quality categories. For some
categories, it was not necessary to meet every corresponding
item; it was sufficient to fulfill a part of the corresponding items
(eg, to fulfill the category sources, the website must contain
either primary information or mention external sources, not
necessarily both of them). None of the websites fulfilled all the
quality criteria and the corresponding categories completely.
Table 4. Quality of information websites (N=693).
n (%)Item
Quality criteria
102 (82.9)Authoring informationa
376 (54.3)Authors
229 (33.0)Sources
467 (67.4)Creation or update date
474 (68.4)Privacy statement
360 (51.9)Declaration of evidence
211 (30.4)Marking of conflicts of interests
643 (92.8)Consideration of target group
99 (80.5)Evaluation of informationa
47 (38.2)Review of informationa
Characteristics of the website (accessibility)
0 (0.0)BITV-Test (barrier-free information technology regulation)
692 (99.9)Font size adjustable
396 (57.1)Consideration of persons with color vision deficiency in coloration
692 (99.9)User can have read out website’s content
689 (99.4)Main menu selectable without a mouse
0 (0.0)Information in simple language
120 (17.3)Newsletter
218 (31.5)Printed version
299 (43.1)Multimedia
638 (92.1)Imprint
687 (99.1)Contact facility
Use of quality certificates
28 (4.0)HONcode
8 (1.2)Medisuch
7 (1.0)Afgis
0 (0.0)Stiftung Gesundheit
a Based on the datasets from the 123 questionnaires that were filled out by the information supplier.
More than 90% of the information suppliers fulfilled the quality
criteria of providing contact facility (687/693, 99.1%), imprint
(638/693, 92.1%), and consideration of target group (643/693,
92.8%). Although important quality criteria for websites
providing information about rare diseases, the criteria declaration
of creation or updating date (467/693, 67.4%) and privacy
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statement (474/693, 68.4%) were met by only approximately
70% of the identified information suppliers.
The information criteria about characteristics of the website
(accessibility) can be divided into several aspects for more
detailed analyses. For instance, 43.1% (299/693) of the websites
provided the information with the support of multimedia, 31.5%
(218/693) also provided printed information, and 17.3%
(120/693) provided an email newsletter service. Moreover,
57.1% (396/693) considered persons with color vision deficiency
in designing their websites. Detailed results are shown in Table
4.
Subgroup analyses were performed for the four most frequent
information supplier categories: support group/patient
organization, medical institution, other associations and
sponsoring bodies, and individuals (patient/relative). Under the
assumption that the fulfillment of every single quality criterion
has equal weight, the quality of information of various
information supplier categories were compared. On the basis
of the 10 quality categories which could be evaluated for all
information providers, statistically significant differences could
be observed for the supplier category individuals
(patient/relative) using a t test analysis. The quality of
information by these suppliers was significantly lower compared
to information provided by support group/patient organization
(P=.001), medical institution (P=.009), and other associations
and sponsoring bodies (P=.001) as well. No statistically
significant differences were observed for the quality of
information provided by support group/patient organization
compared to medical institution (P=.19). Additionally,
information provided by other associations and sponsoring
bodies showed statistically significant differences compared to
that provided by support group/patient organization (P=.007)
and by medical institution (P=.001). The quality of information
provided by other associations and sponsoring bodies was
significantly higher. Figure 1 shows the distribution of
fulfillment of quality criteria by information and supplier
categories.
Figure 1. Fulfilment of quality criteria by information provider.
Discussion
Principal Findings
Information about rare diseases is scarce. In the
German-speaking setting, 693 websites containing information
about rare diseases were identified. In many cases, the quality
of these websites, based on the defined quality criteria for
websites containing information about rare diseases, can be
assessed as insufficient. In addition, quality certificates are rarely
used by information providers of rare diseases.
Particularly, the accessibility of the websites needs to be
improved, although because of browser configuration, the
adjustment of the font size, the selection of the main menu
without a mouse, and the readout of website’s content seems to
be working for most of the websites without any problems.
However, providing information by other means, such as email,
newsletters, and printed versions, is offered only by some
information providers. Support group/patient organizations and
other associations and sponsoring bodies are more commonly
among those who provide access to their information in various
ways. None of the information suppliers provide information
in simple language according to the official rules of the network
of simple language [31]. Additionally, mentioning of sources
of information and disclosing conflicts of interests are seldom
stated, although these are important aspects for assessing
medical or health information. Furthermore, because of rapid
advantages in the development of information and to
demonstrate the latest research findings, the documentation of
the creation or updating date and the declaration of evidence
should be stated more often. On the positive side, an opportunity
to contact the website operator is provided in most cases.
Not all information suppliers provide an adequate imprint and
privacy statement, even though this is required by German law.
In particular, support groups/patient organizations and
individuals (patient/relative) do not provide these kinds of
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information, although their implementation should be rather
straightforward. It can be hypothesized that ignorance and
limited experience prevent these supplier categories presenting
themselves as professionally as other information providers
online. A guidance document for support groups/patient
organizations and individuals could help to improve the
website’s quality.
By far, support groups and patient organizations provide most
of the information websites for rare diseases. This reflects the
importance of support groups for patients suffering from rare
diseases and their relatives [32]. Due to limited knowledge about
the diseases, the insufficient experiences of most of the medical
professionals, and often limited therapeutic approaches, as well
as the low number of affected patients, support groups for
patients with rare diseases are important possibilities to share
knowledge, experiences, and advice with other affected patients.
Support groups and patient organizations for rare diseases
constitute very important sources of information about rare
diseases and contain high potential to solve upcoming research
questions [32]. Moreover, the significant number of identified
websites by individuals providing information about specific
rare diseases shows that these persons feel isolated with the
disease and that they want to make information about themselves
public to get in touch with other people affected by the disorder.
Information about psychosocial counseling and the desire to
have children and/or family planning are rarely presented on
the websites containing information about rare diseases.
Nevertheless, both are important information categories for
patients suffering from a rare disease [26,33] and their relatives
because 80% of all rare diseases have genetic causes [18].
Genetic questions are in line with questions about family
planning and genetic theory. Moreover, because of the low
number of affected persons and the feeling of being overstrained
with the situation of being the only person suffering from this
specific disease, psychosocial counseling constitutes an
important role for all patients. For this, support groups and
patient organizations already provide most of the available
information in the categories of information exchange with other
patients, assistance for self-help, family planning, personal
advice, psychosocial counseling, and social-legal advice.
Nevertheless, information and knowledge about psychosocial
counseling and family planning in the field of rare diseases need
to be extended.
Interestingly, there were no statistically significant differences
identified between the quality of information provided by
support groups/patient organizations and medical institutions.
Only the quality of information provided by other associations
and sponsoring bodies showed statistically better results than
information provided by self-help group/patient organizations
and medical institutions. Overall, cooperation and information
transfer between all supplier categories can help to improve
information quality and information access for patients suffering
from rare diseases, their relatives, and medical professionals.
Especially for rare diseases, cooperation activities can improve
evidence-based clinical and health care research.
Future research on the quality of information about rare diseases
must be considered in a more international context. Especially
for ultrarare diseases, for which limited information is available
and only a few people worldwide are affected, an international
and intercontinental research context is indispensable.
Limitations
This evaluation of quality of information on the Internet about
rare diseases is based on information websites available in the
German language and/or hosted in Germany, Austria, and
Switzerland. Information available on social media accounts
were not included in the analysis [34]. The quality criteria cannot
verify the actual medical content of health information. These
criteria simply verify the factors influencing good thematic
content, as well as the quality of the website itself. An evaluation
of the quality of information about specific disease groups (eg,
rare skin diseases) is not feasible due to the ambiguous
classification of rare diseases provided by Orphanet.
Conclusions
The quality of information on the Internet about rare diseases
was assessed based on 13 quality criteria for websites providing
medical information about rare diseases. Overall, the quality of
information on the Internet about rare diseases is insufficient,
quality certificates are rarely used, and important quality criteria
are often not fulfilled. Subgroup analyses have shown that
information provided by support groups and patient
organizations are as reliable as information provided by medical
institutions. Additionally, there are some information categories
that are underrepresented (eg, information about psychosocial
counseling, social-legal advice, and family planning). These
information categories need to be strongly addressed in future
research on information on websites. Nevertheless, this study
has shown that support groups are extremely important for
patients suffering from a rare disease and their relatives.
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